Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Gibraltar Industries
ROCK
$1.38B
| $9.28M | ﹤0.01% |
147,429
+123,174
| +508% | +$6.66M |
|
2052
PUT
Toast
TOST
$21.4B
| $9.27M | ﹤0.01% |
+410,700
| New | +$8.2M |
|
2053
CALL
D.R. Horton
DHI
$41.7B
| $9.26M | ﹤0.01% |
76,100
+15,700
| +26% | +$1.72M |
|
|
2054
PUT
D.R. Horton
DHI
$41.7B
| $9.25M | ﹤0.01% |
76,000
-82,300
| -52% | -$9M |
|
2055
Global Industrial
GIC
$1.5B
| $9.24M | ﹤0.01% |
332,892
+55,733
| +20% | +$1.44M |
|
2056
EQT Corp
EQT
$34.3B
| $9.23M | ﹤0.01% |
224,457
-1,991,436
| -90% | -$70.4M |
|
2057
iQIYI
IQ
$948M
| $9.23M | ﹤0.01% |
1,727,690
+1,147,961
| +198% | +$6.45M |
|
2058
Camtek
CAMT
$6.69B
| $9.22M | ﹤0.01% |
258,874
-66,850
| -21% | -$1.92M |
|
|
KYNB
2059
Kyntra Bio
KYNB
$32.8M
| $9.2M | ﹤0.01% |
136,336
+112,419
| +470% | +$46.5M |
|
2060
Sabra Healthcare REIT
SBRA
$5.37B
| $9.19M | ﹤0.01% |
780,900
+752,543
| +2,654% | +$8.57M |
|
|
CHUY
2061
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $9.17M | ﹤0.01% |
224,729
-111,721
| -33% | -$4.16M |
|
|
KZR
2062
DELISTED
Kezar Life Sciences
KZR
| $9.17M | ﹤0.01% |
374,111
+120,401
| +47% | +$3.13M |
|
|
GLOP
2063
DELISTED
GASLOG PARTNERS LP
GLOP
| $9.15M | ﹤0.01% |
1,061,530
-909,018
| -46% | -$7.74M |
|
2064
VanEck Junior Gold Miners ETF
GDXJ
$9.78B
| $9.15M | ﹤0.01% |
256,469
+90,599
| +55% | +$3.52M |
|
2065
Navigator Holdings
NVGS
$1.32B
| $9.13M | ﹤0.01% |
702,105
+297,026
| +73% | +$3.95M |
|
2066
CALL
Invesco Solar ETF
TAN
$1.26B
| $9.13M | ﹤0.01% |
127,800
-65,000
| -34% | -$4.69M |
|
|
JKS
2067
JinkoSolar
JKS
$715M
| $9.1M | ﹤0.01% |
205,021
+174,890
| +580% | +$7.91M |
|
2068
Axogen
AXGN
$2.77B
| $9.1M | ﹤0.01% |
996,535
+57,608
| +6% | +$537K |
|
|
IGMS
2069
DELISTED
IGM Biosciences
IGMS
| $9.09M | ﹤0.01% |
984,663
+927,203
| +1,614% | +$10.4M |
|
2070
TripAdvisor
TRIP
$1.16B
| $9.06M | ﹤0.01% |
549,277
+390,240
| +245% | +$6.61M |
|
2071
uniQure
QURE
$3.53B
| $9.05M | ﹤0.01% |
789,502
+440,676
| +126% | +$8.35M |
|
2072
Monro
MNRO
$394M
| $9.05M | ﹤0.01% |
222,683
+196,286
| +744% | +$8.85M |
|
2073
Lincoln Electric
LECO
$15.8B
| $9.03M | ﹤0.01% |
+45,478
| New | +$7.92M |
|
|
SFBS
2074
ServisFirst Bancshares
SFBS
$4.74B
| $9.03M | ﹤0.01% |
441,370
+405,866
| +1,143% | +$9.37M |
|
|
AD
2075
Array Digital Infrastructure
AD
$3.08B
| $9.02M | ﹤0.01% |
511,587
+172,735
| +51% | +$3.08M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.